NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Thanks for the info DD!

Program DAY 1

BTNW Annual Retreat 2022
Wednesday 2nd March

10.30-12.00 Registration/Coffee and Biscuits

12.00-1.15 SESSION 1

1. A. Brodbelt. TRIDENT trial in the UK
2. A.Ali. Prediction of Metastatic Brain Lesions
3. R. Zakaria. Comparison of US and UK Treatment of Tumours
4. J.Kat. Information Recall after Surgical Consultation for High Grade Brain Tumour
5. Z. Khan. Novel Inhibitors of CDK5 for Treatment of Glioblastoma

1.15-2.00 LUNCH

2.00-4.00 SESSION 2

Dr Marnix Bosch – Dendritic Vaccine.

6 R. Alker. Evaluation of Novel Targets for CAR T Therapy in Glioblastoma
7 C. Edwards. Gene Expression Integral to Glutamine Metabolism and Transport in Glioblastoma
8 N. Ahmed. Understanding Changes in Gene Regulation in GBM using Network Analysis
9 N. Shervin. Effects of hypoxia on PMCA Expression in Brain Tumours
10 K. Rzepecka. Effects of GSK 3beta Inhibition in Glioblastoma using Novel Compounds
11 T. Lilo. Raman Hyper spectroscopy Imaging Classification of Meningioma

4.00-4.20 Tea/Coffee

4.20-6.15 SESSION 3

12 S. Beg. Lipid Nanoparticles co-loaded for combination treatment of GBM.
13 S. Bhaduri. IR Spectroscopy as Potential Marker of Treatment Response in Mice
14 S. Bhaduri. Assessing Tumour Haemodynamic Heterogeneity to Choline Kinase Inhibition in Mice
15 E. Whiteside. Longitudinal Study to evaluate Biomarkers in Brain Tumour Patients
16 R. Mathomes. Screening of the ZINC biogenic database for novel glycogen phosphorylase inhibitors

AGM

7/7.30 Conference Dinner